Gout and the risk for coronary artery disease: The MRFIT study by Dr. Eswar Krishnan

Release date: 2009-10-09
Expiration date: 2010-10-09
Estimated time to complete activity: 0.50 hours

Jointly sponsored by:

This activity is supported by an independent educational grant from:

Target Audience
Rheumatologists; other healthcare professionals are invited to participate in this CME activity as well.

Learning Objectives
After viewing this presentation the participant will be able to:
- Screen patients with hyperuricemia and gout in your practice for associated cardiovascular risk factors
- Evaluate the increased risk of acute myocardial infarction due to gout in your middle-aged male patients

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of CME and E-MedHosting.com Inc. The American Academy of CME is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The American Academy of CME designates this educational activity for a maximum of 0.50 AMA PRA Category 1 Credit^™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Method of Participation
There is no fee to participate in this web-based CME activity. In order to receive credit for participation in this CME activity, participants must review the learning objectives, disclosures, complete the pre-test, listen to the web-based presentation, complete the post-test and evaluation form. Participants, who successfully complete the post-test and evaluation form, will have immediate access to their certificate.

Faculty Presenter
Eswar Krishnan MD M.Phil
Asst Professor in Medicine
Division of Immunology and Rheumatology
Stanford University School of Medicine
Palo Alto, CA

Editorial Board

Christie M. Ballantyne, MD Professor of Medicine, Baylor College of Medicine Chief, Section of Atherosclerosis and Vascular Medicine Director, The Maria and Alando J. Ballantyne, M.D., Atherosclerosis Clinical Research Laboratory Director, Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart Center Co-director, Lipid Metabolism and Atherosclerosis Clinic, The Methodist Hospital Houston, TX	Ishwarlal Jialal, MD, PhD Robert E. Stowell Endowed Chair in Experimental Pathology Director of the Laboratory for Atherosclerosis and Metabolic Research Professor of Internal Medicine (Endocrinology, Clinical Nutrition and Vascular Medicine) University of California, Davis Medical Center Davis, CA
James D. Katz, MD, FACP, FACR Associate Professor of Medicine Director, Division of Rheumatology The George Washington University Washington, DC	Wolfgang Koenig, MD, FRCP, FESC, FACC, FAHA Professor of Medicine/Cardiology Director, Department of Internal Medicine II – Cardiology, University of Ulm Medical Center Ulm, Germany
Carlo Louis Mainardi, MD, MBA, FACP, FACR Professor of Clinical Medicine Mt. Sinai School of Medicine New York, NY Vice President for Medical Affairs Newark Beth Israel Medical Center Newark, NJ	Paul M. Ridker, MD, MPH, FACC, FAHA Eugene Braunwald Professor of Medicine, Harvard Medical School Director, Center for Cardiovascular Disease Prevention Divisions of Cardiovascular Diseases and Preventive Medicine Brigham and Women's Hospital Boston, MA

Disclosures of Conflict of Interest
According to the disclosure policy of the American Academy of CME, all faculty, planning committee members, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. Disclosures are listed below:

Dr. Krishnan discloses grant support from and consultancy work for Takeda Pharmaceuticals North America, Inc.; shareholder and advisory board, Savient Pharmaceuticals, Inc. This talk does not discuss off-label use of medications.

Dr. Ballantyne discloses grant/research support from Abbott, ActivBiotics, Gene Logic, GlaxoSmithKline, Integrated Therapeutics, Merck, Pfizer, Schering-Plough, Sanofi-Synthelabo, and Takeda; consultant for Abbott, AstraZeneca, Atherogenics, GlaxoSmithKline, Merck, Merck Schering-Plough, Novartis, Pfizer, Reliant, Schering-Plough, Sanofi-Synthelabo, and Takeda; speakers’ bureau for AstraZeneca, Merck, Pfizer, Reliant, and Schering-Plough.

Dr. Jialal discloses advisory board for marketing purposes for Merck; advisory board for scientific information for Sankyo; grant recipient/research support from American Diabetes Association and Juvenile Diabetes Association; promotional speakers’ bureau for Merck.

Dr. Katz discloses no relevant financial relationship with any commercial interest.

Dr. Koenig discloses advisory board for scientific information for GlaxoSmithKline, Merck-Serono, and Roche; consultant for clinical trial design for Anthera Pharmaceuticals, GlaxoSmithKline, Merck-Serono, and Roche; grant recipient/research support from Dade-Behring and Roche; promotional speakers’ bureau for AstraZeneca, GlaxoSmithKline, Merck, and Novartis.

Dr. Mainardi discloses no relevant financial relationship with any commercial interest.

Dr. Ridker discloses advisory board for scientific information for AstraZeneca, Dade-Behring, Merck, and Schering-Plough; consultant for clinical trial design for AstraZeneca, Novartis, and Sanofi-Aventis; grant recipient/research support for NHLBI, NCI, Reynolds Foundation, Leducq Foundation, Abbott, AstraZeneca, Novartis, and Sanofi-Aventis; intellectual property/patents, Dr. Ridker is listed as a co-inventor on patents held by the Brigham and Women’s Hospital that relate to the use of inflammatory biomarkers in cardiovascular disease.

Planning Committee
Karen Wetzel, John JD Juchniewicz, MCIS, American Academy of CME; Angela Kumar, M.Sc, Heba El-Hakim, B.Sc., E-MedHosting.com Inc. disclosed no relevant financial relationships with any commercial interest.

Contact Information
For any questions, please contact:
American Academy of CME, Inc.
1330 Route 206
Suite 103-600
Skillman, NJ 08558
Phone: 609-921-6622
Fax: 609-921-6428
Email: jjuchniewicz@academycme.org

Privacy Policy
To read about our Privacy Policy, click here

Copyright
CRPhealth.com is owned by E-MedHosting.com Inc. and these CME activities are held as copyrighted © by the American Academy of CME and E-MedHosting.com Inc, Through this notice, the Academy and E-MedHosting.com Inc. grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without the prior permission writing from the copyright owner(s).

SYSTEM REQUIREMENTS

128 MB of RAM or higher recommended (64 MB minimum supported; may limit performance)
800x600 monitor resolution (millions of colors), 16-bit color display or better

Windows®
Processor Pentium 400mhz MMX
Windows 95, 98/NT, XP
16 bits Soundcard, SoundBlaster compatible

Macintosh®
PowerPC G3
Mac OS 9